{"nct_id":"NCT02314247","title":"Efficacy and Safety Study of Selinexor in Relapsed or Refractory Peripheral T-cell Lymphoma or Cutaneous T-cell Lymphoma","status":"TERMINATED","status_verified_date":"2023-01","start_date":"2015-02","start_date_type":null,"primary_completion_date":"2016-01","primary_completion_date_type":"ACTUAL","completion_date":"2016-02","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["KPTI"]}